Research study Program year 2025 Source: CMS Open Payments

Ds5361-061

ClinicalTrials.gov NCT07182591

Research payments

$108,950

10 payments

Through program year 2025, $108,950 in research payments was reported against Ds5361-061, across 10 payments, paid by Daiichi Sankyo Inc..

Paid by
Daiichi Sankyo Inc.
ClinicalTrials.gov
NCT07182591

By program year

1 row
Year Kind Amount Payments
2025 Research $108,950 10

Breakdown

Who paid Research payments · program year 2025
  1. Daiichi Sankyo Inc. $108,950 10 payments
Who received the money Research payments · program year 2025
  1. Next Oncology-San Antonio Organisation paid for research $63,250 7 payments
  2. Sarah Cannon Research Institute Organisation paid for research $45,700 3 payments

Usually the institution or organisation running the study, not a person.

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

3 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record